• DOI:10.1371/journal.pone.0195802
Corpus ID: 5000454

The somatostatin receptor 2 antagonist 64Cu-NODAGA-JR11 outperforms 64Cu-DOTA-TATE in a mouse xenograft model

@article{Rylova2018TheSR,
  title={The somatostatin receptor 2 antagonist 64Cu-NODAGA-JR11 outperforms 64Cu-DOTA-TATE in a mouse xenograft model},
  author={S. Rylova and C. Stoykow and Luigi Del Pozzo and Keelara Abiraj and M. L. Tamma and Y. Kiefer and M. Fani and H. M{\"a}cke},
  journal={PLoS ONE},
  year={2018},
  volume={13}
}

S. Rylova, C. Stoykow, +5 authors H. Mäcke

Published 2018

Chemistry, Medicine

PLoS ONE

Copper-64 is an attractive radionuclide for PET imaging and is frequently used in clinical applications. The aim of this study was to perform a side-by-side comparison of the in vitro and in vivo performance of 64Cu-NODAGA-JR11 (NODAGA = 1,4,7-triazacyclononane,1-glutaric acid,4,7-acetic acid, JR11 = p-Cl-Phe-cyclo(D-Cys-Aph(Hor)-D-Aph(cbm)-Lys-Thr-Cys)D-Tyr-NH2), a somatostatin receptor 2 antagonist, with the clinically used sst2 agonist 64Cu-DOTA-TATE ((TATE = D-Phe-cyclo(Cys-Tyr-D-Trp-Lys… CONTINUE READING

View PDF

Save to Library

Create Alert

Cite

Launch Research Feed